dipyridamole has been researched along with Graft Occlusion, Vascular in 112 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The sensitivity, specificity, positive predictive value, and negative predictive value of the dipyridamole sestamibi stress test (DSST) in predicting graft obstruction or > or = 50% new native coronary artery disease (CAD) in 88 men compared with 56 women with prior coronary artery bypass surgery were 96% and 94% (p = NS), 30% and 67% (p = NS), 91% and 96 % (p = NS), 50% and 57% (p = NS), respectively." | 7.72 | Sensitivity, specificity, positive predictive value, and negative predictive value of the dipyridamole sestamibi stress test in predicting graft occlusion or > or = 50% new native coronary artery disease in men versus women and in patients aged > or = 65 ( Aronow, WS; Cusack, E; Deluca, AJ; Monsen, CE, 2004) |
| "The combination of aspirin and dipyridamole is currently used to prevent intimal hyperplasia and to improve long-term vein graft patency following myocardial revascularization." | 7.67 | Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts. ( Cameron, C; Landymore, RW; MacAulay, M; Sheridan, B, 1986) |
| " Conditions characterized by a reduction in platelet survival and where dipyridamole has been used include heart valve replacement, arterial grafting, cerebrovascular disorders, and disorders of peripheral circulation." | 6.15 | Dipyridamole: a critical evaluation. ( Alexander, MR; Rivey, MP; Taylor, JW, 1984) |
| "Aspirin has been convincingly shown to reduce stroke and death in men with transient ischemic attacks (it may possibly be beneficial to women also), myocardial infarction and death in patients with unstable angina, thromboembolic complications associated with artificial heart valves in patients receiving oral anticoagulants (although gastrointestinal bleeding is prohibitive with this combination), and thrombotic occlusion of silicone rubber arteriovenous cannulae in uremic patients undergoing hemodialysis." | 6.15 | Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. ( Harker, LA, 1986) |
| "In a prospective randomized trial the anti-thrombotic effect of dipyridamole was studied in 64 patients after cadaveric kidney allotransplantation." | 5.06 | [The effect of dipyridamole on the results of allogenic kidney transplantation]. ( Langkopf, B; Schulze, R; Sziegoleit, W, 1990) |
| "To study the prevention of occlusion of aortocoronary-artery bypass grafts, we conducted a prospective, randomized, double-blind trial comparing long-term administration of dipyridamole (begun 2 days before operation) plus aspirin (begun 7 hr after operation) with placebo in 407 patients." | 3.76 | Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. ( Chesebro, JH; Fuster, V, 1986) |
| "The sensitivity, specificity, positive predictive value, and negative predictive value of the dipyridamole sestamibi stress test (DSST) in predicting graft obstruction or > or = 50% new native coronary artery disease (CAD) in 88 men compared with 56 women with prior coronary artery bypass surgery were 96% and 94% (p = NS), 30% and 67% (p = NS), 91% and 96 % (p = NS), 50% and 57% (p = NS), respectively." | 3.72 | Sensitivity, specificity, positive predictive value, and negative predictive value of the dipyridamole sestamibi stress test in predicting graft occlusion or > or = 50% new native coronary artery disease in men versus women and in patients aged > or = 65 ( Aronow, WS; Cusack, E; Deluca, AJ; Monsen, CE, 2004) |
| "The combination of aspirin and dipyridamole is currently used to prevent intimal hyperplasia and to improve long-term vein graft patency following myocardial revascularization." | 3.67 | Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts. ( Cameron, C; Landymore, RW; MacAulay, M; Sheridan, B, 1986) |
| "Treatment with dipyridamole plus aspirin significantly prolonged the duration of primary unassisted patency (hazard ratio, 0." | 2.74 | Effect of dipyridamole plus aspirin on hemodialysis graft patency. ( Allon, M; Beck, GJ; Braden, GL; Cotton, JR; Davidson, IJ; Delmez, JA; Dember, LM; Dixon, BS; Feldman, HI; Fenves, AZ; Gassman, JJ; Greenberg, A; Greene, T; Himmelfarb, J; Hu, B; Ikizler, TA; Kaufman, JS; Kusek, JW; Lawson, JH; Martin, KJ; McNeil, JW; Meyers, CM; Radeva, MK; Rahman, A; Vazquez, MA; Whiting, JF, 2009) |
| "Indobufen is a possible alternative antiplatelet agent that may be better tolerated." | 2.67 | Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. ( Beton, D; Campbell, C; Critchley, A; Lawson, RA; Nair, U; Rajah, SM; Rees, M; Saunders, N; Walker, D; Williams, G, 1994) |
| "Aspirin was initiated either 12 hours before or 6 hours after operation." | 2.67 | Internal mammary artery and saphenous vein graft patency. Effects of aspirin. ( Copeland, J; Goldman, S; Henderson, W; Kern, KB; Khuri, S; Moritz, T; Ovitt, T; Sethi, G; Sharma, GV; Zadina, K, 1990) |
| "For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (last searched June 2014) and the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 5)." | 2.52 | Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. ( Acosta, S; Bedenis, R; Lethaby, A; Maxwell, H; Prins, MH, 2015) |
| " A low (100 mg) to medium (325 mg) daily aspirin dosage was more effective than a high dose (975 mg)." | 2.38 | Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis. ( Chen, E; Christakis, GT; Fremes, SE; Goldman, BS; Levinton, C; Naylor, CD, 1993) |
| " The pharmacokinetic parameters and resulting computational simulations are helpful in exploring perivascular drug delivery strategies." | 1.33 | Perivascular tissue pharmacokinetics of dipyridamole. ( Cheung, AK; Goteti, K; Kern, SE; Kuji, T; Leypoldt, JK; Masaki, T, 2006) |
| "Dipyridamole is a potential pharmacological agent to prevent vascular stenosis because of its antiproliferative properties." | 1.33 | Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation. ( Blumenthal, DK; Cheung, AK; Masaki, T; Zhuplatov, SB, 2006) |
| "Dipyridamole induced an increase in the DPV respectively of 86." | 1.32 | Noninvasive assessment of left and right internal mammary artery graft patency using transthoracic color Doppler echocardiography. ( Bonzani, G; Caso, P; Cicala, S; Cotrufo, M; De Simone, L; Galderisi, M; Mininni, N; Renzulli, A; Scherillo, M; Severino, S, 2003) |
| "Indications for surgery included vertebrobasilar insufficiency (22." | 1.30 | Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy. ( Dresler, C; Haverich, A; Wahlers, T; Wittwer, T, 1998) |
| "Graft success was evaluated by patency, thrombus-free surface area, area endothelialized, and graft production of prostacyclin." | 1.27 | Effects of antiplatelet agents in combination with endothelial cell seeding on small-diameter Dacron vascular graft performance in the canine carotid artery model. ( Evancho, MM; Falkow, LJ; Hunter, TJ; Schmidt, SP; Sharp, WV, 1985) |
| " Possible explanations for these negative findings include inadequate dosage or form of omega-3 fatty acids and the antiplatelet drugs administered, excessive variability in graft response due to uncharacterized immunologic histocompatibility, and the possible influence of non-platelet-mediated mechanisms." | 1.27 | Effects of aspirin, dipyridamole, and cod liver oil on accelerated myointimal proliferation in canine veno-arterial allografts. ( DeCampli, WM; Handen, CE; Kosek, JC; Miller, DC; Mitchell, RS, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (38.39) | 18.7374 |
| 1990's | 49 (43.75) | 18.2507 |
| 2000's | 15 (13.39) | 29.6817 |
| 2010's | 5 (4.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nee, R | 1 |
| Parker, AL | 1 |
| Little, DJ | 1 |
| Yuan, CM | 1 |
| Himmelfarb, J | 4 |
| Lowe, SR | 1 |
| Abbott, KC | 1 |
| Mannacio, V | 1 |
| De Vita, A | 1 |
| Antignano, A | 1 |
| Mottola, M | 1 |
| Di Tommaso, L | 1 |
| Graniero, A | 1 |
| Vosa, C | 1 |
| Bedenis, R | 1 |
| Lethaby, A | 1 |
| Maxwell, H | 1 |
| Acosta, S | 1 |
| Prins, MH | 1 |
| Dixon, BS | 2 |
| Beck, GJ | 2 |
| Vazquez, MA | 1 |
| Greenberg, A | 1 |
| Delmez, JA | 1 |
| Allon, M | 1 |
| Dember, LM | 2 |
| Gassman, JJ | 2 |
| Greene, T | 2 |
| Radeva, MK | 1 |
| Davidson, IJ | 1 |
| Ikizler, TA | 1 |
| Braden, GL | 1 |
| Fenves, AZ | 1 |
| Kaufman, JS | 2 |
| Cotton, JR | 1 |
| Martin, KJ | 1 |
| McNeil, JW | 1 |
| Rahman, A | 1 |
| Lawson, JH | 2 |
| Whiting, JF | 2 |
| Hu, B | 1 |
| Meyers, CM | 2 |
| Kusek, JW | 1 |
| Feldman, HI | 2 |
| Lok, CE | 1 |
| Weale, AR | 1 |
| Cooper, DG | 1 |
| Hentschel, DM | 1 |
| Veeger, NJ | 1 |
| Zijlstra, F | 1 |
| Hillege, HL | 3 |
| van der Meer, J | 4 |
| Hiratzka, LF | 1 |
| Fusejima, K | 1 |
| Masuda, Y | 1 |
| Ishikawa, T | 1 |
| Shiotsuki, Y | 1 |
| De Simone, L | 1 |
| Caso, P | 1 |
| Severino, S | 1 |
| Cicala, S | 1 |
| Galderisi, M | 1 |
| Renzulli, A | 1 |
| Bonzani, G | 1 |
| Scherillo, M | 1 |
| Mininni, N | 1 |
| Cotrufo, M | 1 |
| Chirillo, F | 1 |
| Bruni, A | 1 |
| De Leo, A | 1 |
| Olivari, Z | 1 |
| Franceschini-Grisolia, E | 1 |
| Totis, O | 1 |
| Stritoni, P | 1 |
| Deluca, AJ | 1 |
| Cusack, E | 1 |
| Aronow, WS | 1 |
| Monsen, CE | 1 |
| Depner, TA | 1 |
| Hunsicker, LG | 1 |
| Middleton, JP | 1 |
| Radeva, M | 1 |
| Schwab, SJ | 1 |
| Goteti, K | 2 |
| Masaki, T | 4 |
| Kuji, T | 2 |
| Leypoldt, JK | 2 |
| Cheung, AK | 4 |
| Kern, SE | 3 |
| Li, L | 1 |
| Zhuplatov, S | 1 |
| Terry, CM | 1 |
| Zhu, W | 2 |
| Rathi, R | 1 |
| Blumenthal, DK | 2 |
| Zhuplatov, SB | 1 |
| Stauder, NI | 1 |
| Klumpp, B | 1 |
| Stauder, H | 1 |
| Blumenstock, G | 1 |
| Fenchel, M | 1 |
| Küttner, A | 1 |
| Claussen, CD | 1 |
| Miller, S | 1 |
| Hillis, LD | 1 |
| Kon, ND | 2 |
| Hansen, KJ | 2 |
| Martin, MB | 1 |
| Meredith, JW | 1 |
| Meredith, JH | 2 |
| Cordell, AR | 1 |
| Rivey, MP | 1 |
| Alexander, MR | 1 |
| Taylor, JW | 1 |
| Lindblad, B | 1 |
| Wakefield, TW | 1 |
| Stanley, TJ | 1 |
| Bergqvist, D | 1 |
| Nichol, BJ | 1 |
| Greenfield, LJ | 1 |
| Stanley, JC | 1 |
| Bergentz, SE | 1 |
| Isakov, A | 1 |
| Shapira, I | 1 |
| London, NJ | 1 |
| Varty, K | 1 |
| Thompson, M | 1 |
| Sayers, RD | 1 |
| Bell, PR | 1 |
| Brutel de la Rivière, A | 1 |
| van Gilst, WH | 2 |
| Pfisterer, M | 5 |
| Kootstra, GJ | 2 |
| Dunselman, PH | 1 |
| Mulder, BJ | 3 |
| Lie, KI | 2 |
| Edmondson, RA | 1 |
| Cohen, AT | 1 |
| Das, SK | 1 |
| Wagner, MB | 1 |
| Kakkar, VV | 1 |
| van der Doef, RM | 1 |
| van der Wall, EE | 1 |
| Tijssen, JG | 1 |
| Piek, JJ | 1 |
| Dunning, AJ | 1 |
| Sreedhara, R | 1 |
| Lazarus, JM | 1 |
| Hakim, RM | 1 |
| Ascoop, CA | 1 |
| Loeliger, EA | 4 |
| Houben, JJ | 2 |
| Nicolai, G | 2 |
| Visser, J | 1 |
| Rajah, SM | 2 |
| Nair, U | 1 |
| Rees, M | 1 |
| Saunders, N | 1 |
| Walker, D | 1 |
| Williams, G | 1 |
| Critchley, A | 1 |
| Beton, D | 1 |
| Campbell, C | 1 |
| Lawson, RA | 1 |
| Bearn, PE | 2 |
| Bull, H | 2 |
| Seddon, AM | 2 |
| Marston, A | 2 |
| McCollum, CN | 4 |
| Cataldo, G | 3 |
| Braga, M | 1 |
| Pirotta, N | 1 |
| Lavezzari, M | 2 |
| Rovelli, F | 2 |
| Marubini, E | 3 |
| Hess, F | 2 |
| Steeghs, S | 2 |
| Jerusalem, R | 1 |
| Reijnders, O | 1 |
| Jerusalem, C | 2 |
| Braun, B | 2 |
| Grande, P | 2 |
| Hockings, BE | 1 |
| Ireland, MA | 1 |
| Gotch-Martin, KF | 1 |
| Taylor, RR | 1 |
| Rohn, V | 2 |
| Pirk, J | 3 |
| Mach, T | 1 |
| Sarin, S | 1 |
| Shami, SK | 1 |
| Cheatle, TR | 1 |
| Bearn, P | 1 |
| Scurr, JH | 1 |
| Coleridge Smith, PD | 1 |
| Moffat, C | 1 |
| Fox, B | 1 |
| Fremes, SE | 1 |
| Levinton, C | 1 |
| Naylor, CD | 1 |
| Chen, E | 1 |
| Christakis, GT | 1 |
| Goldman, BS | 1 |
| Pezzano, A | 1 |
| Fusco, R | 1 |
| Child, M | 1 |
| Riccobono, S | 1 |
| Milazzo, A | 1 |
| Recalcati, F | 1 |
| Savonitto, S | 1 |
| Wittwer, T | 1 |
| Wahlers, T | 1 |
| Dresler, C | 1 |
| Haverich, A | 1 |
| Rombaut, E | 1 |
| Vantrimpont, P | 1 |
| Gurné, O | 1 |
| Chenu, P | 1 |
| Schroeder, E | 1 |
| Buche, M | 1 |
| Louagie, Y | 1 |
| Eucher, P | 1 |
| Marchandise, B | 1 |
| Heiman, F | 1 |
| Stein, PD | 1 |
| Dalen, JE | 1 |
| Goldman, S | 4 |
| Théroux, P | 1 |
| Moreno, R | 1 |
| García-Fernández, MA | 1 |
| Moreno, M | 1 |
| Bermejo, J | 1 |
| Silva, J | 1 |
| Vallejo, JL | 1 |
| Delcán, JL | 1 |
| Gottsauner-Wolf, M | 1 |
| Zasmeta, G | 1 |
| Hornykewycz, S | 1 |
| Nikfardjam, M | 1 |
| Stepan, E | 1 |
| Wexberg, P | 1 |
| Zorn, G | 1 |
| Glogar, D | 1 |
| Probst, P | 1 |
| Maurer, G | 1 |
| Huber, K | 1 |
| Ishida, N | 1 |
| Sakuma, H | 1 |
| Cruz, BP | 1 |
| Shimono, T | 1 |
| Tokui, T | 1 |
| Yada, I | 1 |
| Takeda, K | 1 |
| Higgins, CB | 1 |
| Yli-Mäyry, S | 1 |
| Huikuri, HV | 1 |
| Korhonen, UR | 1 |
| Airaksinen, KE | 1 |
| Ikäheimo, MJ | 1 |
| Linnaluoto, MK | 1 |
| Takkunen, JT | 1 |
| Chong, BH | 1 |
| Agnew, TM | 1 |
| French, JK | 1 |
| Neutze, JM | 1 |
| Whitlock, RM | 1 |
| Brandt, PW | 1 |
| Kerr, AR | 1 |
| Webber, BJ | 1 |
| Rutherford, JD | 1 |
| Yamaguchi, A | 1 |
| Kitamura, N | 1 |
| Miki, T | 1 |
| Tatebayashi, T | 1 |
| Kawashima, M | 1 |
| Otaki, M | 1 |
| Tamura, H | 1 |
| Sagnol, P | 1 |
| Delahaye, JP | 1 |
| McCollum, C | 2 |
| Kenchington, G | 2 |
| Alexander, C | 2 |
| Franks, PJ | 2 |
| Greenhalgh, RM | 1 |
| Montoro, C | 1 |
| Mezzanotte, G | 1 |
| Petroccione, A | 1 |
| Greenhalgh, R | 1 |
| Bongo, AS | 1 |
| Bolognese, L | 1 |
| Sarasso, G | 1 |
| Cernigliaro, C | 1 |
| Aralda, D | 1 |
| Carfora, A | 1 |
| Piccinino, C | 1 |
| Campi, A | 1 |
| Rossi, L | 1 |
| Rossi, P | 1 |
| Ollivier, JP | 1 |
| Burkart, F | 3 |
| Jockers, G | 3 |
| Meyer, B | 2 |
| Regenass, S | 2 |
| Burckhardt, D | 2 |
| Schmitt, HE | 3 |
| Müller-Brand, J | 2 |
| Skarvan, K | 2 |
| Stulz, P | 3 |
| Sanz, G | 2 |
| Chesebro, JH | 7 |
| Bech, FR | 1 |
| Cronenwett, JL | 1 |
| McDaniel, MD | 1 |
| Ogletree, ML | 1 |
| Freeman, DH | 1 |
| Schulze, R | 1 |
| Langkopf, B | 1 |
| Sziegoleit, W | 1 |
| Pajarón, A | 1 |
| Alegría, E | 1 |
| Coello, I | 1 |
| Cardona, M | 1 |
| Fournier, JA | 1 |
| Gómez-Recio, M | 1 |
| Ruano, J | 1 |
| Hidalgo, R | 1 |
| Medina, A | 1 |
| Peregrin, J | 1 |
| Copeland, J | 2 |
| Moritz, T | 3 |
| Henderson, W | 2 |
| Zadina, K | 3 |
| Ovitt, T | 2 |
| Kern, KB | 1 |
| Sethi, G | 1 |
| Sharma, GV | 1 |
| Khuri, S | 1 |
| Buring, JE | 1 |
| Hennekens, CH | 1 |
| Sethi, GK | 1 |
| Copeland, JG | 1 |
| Henderson, WG | 1 |
| Doherty, J | 1 |
| Read, R | 1 |
| Chesler, E | 1 |
| Sako, Y | 1 |
| Schmidt, SP | 2 |
| Hunter, TJ | 2 |
| Falkow, LJ | 1 |
| Evancho, MM | 2 |
| Sharp, WV | 2 |
| Stratton, JR | 1 |
| Ritchie, JL | 1 |
| Fuster, V | 6 |
| Gershlick, AH | 2 |
| Lyons, JP | 1 |
| Wright, JE | 1 |
| Sturridge, MF | 1 |
| Layton, CA | 1 |
| Balcon, R | 2 |
| Goldman, M | 1 |
| Steele, PM | 1 |
| van Det, R | 1 |
| Skotnicki, S | 1 |
| DeCampli, WM | 1 |
| Kosek, JC | 1 |
| Mitchell, RS | 1 |
| Handen, CE | 1 |
| Miller, DC | 1 |
| Suma, H | 1 |
| Takeuchi, A | 1 |
| Sasaki, S | 1 |
| Asada, K | 1 |
| Suwa, M | 1 |
| Hirota, Y | 1 |
| Ekeström, S | 2 |
| Bergdahl, L | 1 |
| Meier, B | 1 |
| Hasse, J | 1 |
| Grädel, E | 1 |
| Limet, R | 1 |
| Thaulow, E | 1 |
| Frøysaker, T | 1 |
| Dale, J | 1 |
| Vatne, K | 1 |
| Harker, LA | 2 |
| Clowes, AW | 1 |
| Verstraete, M | 1 |
| Brown, BG | 2 |
| Henderson, AH | 1 |
| Jewitt, DE | 1 |
| Oliver, MF | 1 |
| Sleight, P | 1 |
| Patrono, C | 1 |
| Vojácek, J | 1 |
| Kovác, J | 1 |
| Hirko, MK | 1 |
| Donovan, DL | 1 |
| David, JL | 1 |
| Hasegawa, T | 1 |
| Hasegawa, S | 1 |
| Fukushima, K | 1 |
| Watanabe, N | 1 |
| Yokoyama, H | 1 |
| Rosenthal, D | 1 |
| Mittenthal, MJ | 1 |
| Ruben, DM | 1 |
| Jones, DH | 1 |
| Estes, JW | 1 |
| Stanton, PE | 1 |
| Lamis, PA | 1 |
| Lane, IF | 1 |
| Irwin, JT | 1 |
| Jennings, SA | 1 |
| Poskitt, KR | 1 |
| Meek, AC | 1 |
| Howe, HR | 1 |
| Edgerton, TA | 1 |
| Faust, KB | 1 |
| Geisinger, KR | 1 |
| Nordestgaard, AG | 1 |
| Buckels, JA | 1 |
| Wilson, SE | 1 |
| Cukingnan, RA | 1 |
| DeRouen, T | 1 |
| Goede, LV | 1 |
| Wong, M | 1 |
| Fee, HJ | 1 |
| Roth, JA | 1 |
| Carey, JS | 1 |
| Brooks, N | 1 |
| Wright, J | 1 |
| Sturridge, M | 1 |
| Pepper, J | 1 |
| Magee, P | 1 |
| Walesby, R | 1 |
| Layton, C | 1 |
| Honey, M | 1 |
| Salter, MC | 1 |
| Donaldson, DR | 1 |
| Subba Rao, R | 1 |
| Boyle, RM | 1 |
| Partridge, JB | 1 |
| Watson, DA | 1 |
| Bourassa, MG | 1 |
| Fisher, LD | 1 |
| Campeau, L | 1 |
| Gillespie, MJ | 1 |
| McConney, M | 1 |
| Lespérance, J | 1 |
| Chesebro, JJ | 1 |
| Syndercombe Court, YD | 1 |
| Murday, AJ | 1 |
| Lewis, CT | 1 |
| Mills, PG | 1 |
| Landymore, RW | 1 |
| MacAulay, M | 1 |
| Sheridan, B | 1 |
| Cameron, C | 1 |
| Boerboom, LE | 1 |
| Olinger, GN | 1 |
| Bonchek, LI | 1 |
| Gunay, II | 1 |
| Kissebah, AH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency[NCT00067119] | Phase 3 | 649 participants (Actual) | Interventional | 2003-01-01 | Completed | ||
| Effect of Beraprost Sodium (Berasil) on Hemodialysis[NCT03142360] | 60 participants (Anticipated) | Interventional | 2017-04-05 | Recruiting | |||
| A Randomized Comparison of Low-dose Versus High-dose Rosuvastatin on Optical Coherence Tomography Based Early Vascular Healing for Patients With Acute Coronary Syndrome[NCT03007524] | Phase 4 | 80 participants (Anticipated) | Interventional | 2016-07-31 | Recruiting | ||
| Effect of Low Molecular Weight Heparin vs Unfractionated Heparin on Bleeding After Cardiac Surgery[NCT00420667] | 43 participants (Actual) | Interventional | 2004-11-30 | Completed | |||
| Intraoperative Optical Coherence Tomography of the Saphenous Vein Conduit in Patients Undergoing Coronary Artery Bypass Surgery[NCT05129228] | 760 participants (Anticipated) | Interventional | 2022-04-04 | Recruiting | |||
| [NCT00000489] | Phase 3 | 0 participants | Interventional | 1973-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for dipyridamole and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
Topics: Anastomosis, Surgical; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vas | 2015 |
[Transthoracic evaluation of coronary artery stenotic lesions using color Doppler echocardiography].
Topics: Coronary Artery Bypass; Coronary Circulation; Coronary Stenosis; Dipyridamole; Echocardiography, Dop | 1994 |
Percutaneous transluminal coronary angioplasty.
Topics: Angina, Unstable; Angioplasty, Balloon; Animals; Aspirin; Calcium Channel Blockers; Coronary Artery | 1984 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1984 |
When do vascular surgeons prescribe antiplatelet therapy? Current attitudes.
Topics: Angioplasty, Balloon; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vascular; Humans; Is | 1993 |
Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occl | 1993 |
[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Me | 1991 |
Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: the basis of their use, data from animal studies, clinical trial data, and current recommendations.
Topics: Angioplasty, Balloon; Animals; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Coronar | 1986 |
Coronary artery bypass grafting. A model for the understanding of the progression of atherosclerotic disease and the role of pharmacological intervention.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Collagen; Coronary Artery Bypass | 1985 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; D | 1986 |
Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
Topics: Angina, Unstable; Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disea | 1986 |
Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.
Topics: Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up Studies; | 1985 |
Aortocoronary artery vein-graft disease: experimental and clinical approach for the understanding of the role of platelets and platelet inhibitors.
Topics: Animals; Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Dogs; Gra | 1985 |
50 trials available for dipyridamole and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Cost-effectiveness of antiplatelet therapy to prolong primary patency of hemodialysis graft.
Topics: Adult; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Cost-Benefit | 2014 |
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 2009 |
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 2009 |
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 2009 |
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 2009 |
Fourteen-year follow-up from CABADAS: vitamin K antagonists or dipyridamole not superior to aspirin.
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Female; Follow-U | 2010 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1984 |
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Inst
Topics: Acenocoumarol; Anticoagulants; Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination | 1994 |
Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
Topics: Adult; Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusi | 1994 |
Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Circulation; C | 1994 |
Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Double-Blind Method; | 1994 |
Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Ne
Topics: Acenocoumarol; Administration, Oral; Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Thera | 1993 |
Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
Topics: Adolescent; Adult; Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Th | 1994 |
Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).
Topics: Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Female; Gr | 1993 |
[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans | 1993 |
[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; | 1993 |
Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.
Topics: Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Female; Follow-Up Studies; | 1993 |
[The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
Topics: Adult; Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Female; Graft Occlusion, Vascular; Human | 1993 |
Plasma levels of C-reactive protein after coronary stent implantation.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Coronary An | 2000 |
Efficacy and safety of anticoagulant therapy started pre-operatively in preventing coronary vein graft occlusion.
Topics: Aspirin; Cardiac Catheterization; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Thera | 1992 |
The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts.
Topics: Aged; Aspirin; Cardiac Catheterization; Cineangiography; Coronary Artery Bypass; Dipyridamole; Drug | 1992 |
[Comparative study of anticoagulant management after coronary artery bypass surgery--warfarin versus dipyridamole].
Topics: Adult; Aged; Anticoagulants; Chi-Square Distribution; Coronary Artery Bypass; Dipyridamole; Female; | 1992 |
[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Me | 1991 |
PTFE or HUV for femoro-popliteal bypass: a multi-centre trial.
Topics: Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Blood Vessel Prosthesis; Combined Modality Ther | 1991 |
A linear model suitable for assessing graft patency in controlled clinical trials. SINBA Group.
Topics: Anastomosis, Surgical; Angiography; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyr | 1990 |
Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
Topics: Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Femoral Artery; Follow-Up Stu | 1991 |
[Permeability of aortocoronary bypass after 6 months. A multicenter French study].
Topics: Adult; Aged; Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Female; Follow-Up | 1991 |
Prevention of aortocoronary vein bypass graft occlusion: which antithrombotic treatment and for how long?
Topics: Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Dru | 1990 |
Does low-dose aspirin prevent aortocoronary vein bypass graft occlusion? The Spanish Group for Aortocoronary Bypass Follow-up (GESIC Study).
Topics: Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 1990 |
Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; | 1990 |
[The effect of dipyridamole on the results of allogenic kidney transplantation].
Topics: Cadaver; Dipyridamole; Graft Occlusion, Vascular; Graft Rejection; Humans; Infusions, Intravenous; K | 1990 |
Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC)
Topics: Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Combinations; Graft Occlusion, Vascular; H | 1990 |
The effect of ibustrin on early aortocoronary bypass patency.
Topics: Angiography, Digital Subtraction; Aspirin; Coronary Angiography; Coronary Artery Bypass; Coronary Di | 1990 |
Internal mammary artery and saphenous vein graft patency. Effects of aspirin.
Topics: Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Graft Occl | 1990 |
Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy.
Topics: Aspirin; Blood Transfusion; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Graft Occlusi | 1990 |
Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
Topics: 4-Hydroxycoumarins; Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary | 1989 |
Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Graft Occlusion, Vascular; Human | 1989 |
Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: the basis of their use, data from animal studies, clinical trial data, and current recommendations.
Topics: Angioplasty, Balloon; Animals; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Coronar | 1986 |
Long term clinical outcome of coronary surgery and assessment of the benefit obtained with postoperative aspirin and dipyridamole.
Topics: Angina Pectoris; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up | 1988 |
Platelet-inhibitory therapy in reconstructive arterial surgery.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Bli | 1985 |
[Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Pl | 1987 |
Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary venous bypass graft.
Topics: Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Drug Combinations; Graft Occlus | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; D | 1986 |
The role of aspirin in enhancing arterial graft patency.
Topics: Animals; Arteries; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamole; Drug Th | 1986 |
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary A | 1986 |
Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
Topics: Angina, Unstable; Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disea | 1986 |
Improvement of aortocoronary bypass patency by antiplatelet drug administration. Preliminary communication.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up | 1986 |
Pathogenesis and prevention of aortocoronary bypass graft occlusion.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug T | 1986 |
Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.
Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Di | 1985 |
Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind M | 1985 |
Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
Topics: Adult; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; | 1985 |
Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.
Topics: Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up Studies; | 1985 |
55 other studies available for dipyridamole and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Y grafts with the left internal mammary artery and radial artery. Mid-term functional and angiographic results. Cohort study.
Topics: Aged; Angiography; Cohort Studies; Coronary Artery Bypass, Off-Pump; Coronary Circulation; Dipyridam | 2014 |
Antiplatelet therapy and vascular-access patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vasc | 2009 |
Dipyridamole plus aspirin and hemodialysis graft patency.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular | 2009 |
Dipyridamole plus aspirin and hemodialysis graft patency.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination; General Surgery; Graft Oc | 2009 |
Invited commentary.
Topics: Acenocoumarol; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascu | 2010 |
Noninvasive assessment of left and right internal mammary artery graft patency using transthoracic color Doppler echocardiography.
Topics: Blood Flow Velocity; Coronary Angiography; Coronary Artery Bypass; Diastole; Dipyridamole; Echocardi | 2003 |
Usefulness of dipyridamole stress echocardiography for predicting graft patency after coronary artery bypass grafting.
Topics: Aged; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coronary Vessels; Dipyrida | 2004 |
Sensitivity, specificity, positive predictive value, and negative predictive value of the dipyridamole sestamibi stress test in predicting graft occlusion or > or = 50% new native coronary artery disease in men versus women and in patients aged > or = 65
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Coronary Artery Bypass; Coronary Artery Disease; Dipyri | 2004 |
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
Topics: Algorithms; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Delayed- | 2005 |
Perivascular tissue pharmacokinetics of dipyridamole.
Topics: Algorithms; Animals; Biological Transport, Active; Blood Pressure; Blood Vessels; Carotid Arteries; | 2006 |
Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis.
Topics: Animals; Arteriovenous Shunt, Surgical; Carotid Arteries; Cell Proliferation; Delayed-Action Prepara | 2006 |
Cellular pharmacokinetics and pharmacodynamics of dipyridamole in vascular smooth muscle cells.
Topics: Animals; Cell Line; Cell Proliferation; Dipyridamole; Drug Delivery Systems; Graft Occlusion, Vascul | 2006 |
Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation.
Topics: Aorta; Cell Cycle; Cell Proliferation; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kin | 2006 |
Assessment of coronary artery bypass grafts by magnetic resonance imaging.
Topics: Aged; Blood Flow Velocity; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coron | 2007 |
Inhibition of platelet deposition on polytetrafluoroethylene grafts by antiplatelet agents.
Topics: Animals; Blood Vessel Prosthesis; Depression, Chemical; Dipyridamole; Dogs; Epoprostenol; Graft Occl | 1984 |
Pharmacological prophylaxis against postoperative graft occlusion after peripheral vascular surgery: a world-wide survey.
Topics: Anticoagulants; Aspirin; Data Collection; Dipyridamole; Drug Utilization; Graft Occlusion, Vascular; | 1995 |
[Dipyridamole after aortocoronary bypass--treatment or tradition].
Topics: Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans | 1995 |
Low-molecular-weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
Topics: Anastomosis, Surgical; Aspirin; Dipyridamole; Drug Combinations; Femoral Artery; Graft Occlusion, Va | 1994 |
Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, C | 1993 |
Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Aspirin; Coronary Artery Bypass; Data Interpretation, Statisti | 1993 |
[No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans | 1994 |
The effect of platelet inhibitory therapy on graft thromboresistance.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Drug Th | 1993 |
Patency and morphology of fibrous polyurethane vascular prostheses implanted in the femoral artery of dogs after seeding with subcultivated endothelial cells.
Topics: Anastomosis, Surgical; Animals; Aspirin; Blood Vessel Prosthesis; Cells, Cultured; Dipyridamole; Dog | 1993 |
The effect of platelet inhibitory therapy on prosthetic graft maturation.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Drug Therapy, Combination; Female; Fe | 1993 |
Assessment of left internal mammary artery grafts using dipyridamole Doppler echocardiography.
Topics: Blood Flow Velocity; Coronary Circulation; Diastole; Dipyridamole; Echocardiography, Doppler, Color; | 1997 |
Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy.
Topics: Adult; Aged; Angiography; Anticoagulants; Arm; Arterial Occlusive Diseases; Aspirin; Blood Vessel Pr | 1998 |
Noninvasive functional assessment of left internal mammary artery grafts by transcutaneous Doppler echocardiography.
Topics: Adult; Aged; Blood Flow Velocity; Coronary Circulation; Dipyridamole; Echocardiography, Doppler; Fea | 1998 |
Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
Topics: Aspirin; Coronary Artery Bypass; Cyclooxygenase Inhibitors; Dipyridamole; Drug Therapy, Combination; | 1998 |
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Graft Occlusion, | 1998 |
[The Doppler color detection of internal mammary artery anastomoses and a functional assessment of their patency].
Topics: Aged; Cardiac Catheterization; Coronary Angiography; Coronary Circulation; Coronary Vessels; Dipyrid | 1999 |
Mr flow measurement in the internal mammary artery-to-coronary artery bypass graft: comparison with graft stenosis at radiographic angiography.
Topics: Aged; Aged, 80 and over; Angiography; Coronary Artery Bypass; Coronary Vessels; Dipyridamole; Female | 2001 |
Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion.
Topics: Aspirin; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Graft Occlusion, Vascular; Humans | 1992 |
Early assessment of coronary artery bypass graft patency by high-dose dipyridamole echocardiography.
Topics: Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Echocardiography; Elec | 1991 |
The effect of thromboxane receptor blockade versus thromboxane synthase inhibition on canine arterial graft patency.
Topics: Animals; Aspirin; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Dipyridamole; Dogs; Fatty Ac | 1990 |
Antiplatelet therapy to prevent coronary artery bypass graft occlusion.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Combinations; Graft Occlusion, Vascular; Humans; | 1990 |
Dipyridamole.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; | 1989 |
Effects of antiplatelet agents in combination with endothelial cell seeding on small-diameter Dacron vascular graft performance in the canine carotid artery model.
Topics: Animals; Aspirin; Benzofurans; Blood Platelets; Blood Vessel Prosthesis; Carotid Arteries; Dipyridam | 1985 |
Reduction of indium-111 platelet deposition on Dacron vascular grafts in humans by aspirin plus dipyridamole.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Graft Occlusion, Vascular; Humans; Indium; Male | 1986 |
Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Bioprosthesis; Blood Platelets; Coronary Disease; Dip | 1985 |
Patency rate of small caliber fibrous polyurethane vascular prostheses implanted in the dog carotid and femoral artery improved by use of acetylsalicylic acid and dipyridamol.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Carotid Arteries; Dipyridamole; Dogs; Female; Femoral Art | 1988 |
Effects of aspirin, dipyridamole, and cod liver oil on accelerated myointimal proliferation in canine veno-arterial allografts.
Topics: Animals; Aspirin; Cholesterol, Dietary; Cod Liver Oil; Dipyridamole; Dogs; Elastic Tissue; Endotheli | 1988 |
[Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occl | 1988 |
Augmentation of coronary bypass graft flow induced by dipyridamole and its relation to bypass graft patency.
Topics: Administration, Oral; Blood Pressure; Coronary Artery Bypass; Coronary Circulation; Dipyridamole; Gr | 1988 |
The immediate function of sequential aortocoronary vein grafts to closely adjacent myocardial areas.
Topics: Blood Flow Velocity; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Myocar | 1986 |
[Role of platelet anti-aggregants in cardiovascular surgery].
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Platelet Aggregati | 1987 |
Endothelial cell seeding improves 4 mm PTFE vascular graft performance in antiplatelet medicated dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamo | 1987 |
[Mode of action and clinical evaluation of platelet aggregation inhibitors].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Graft Occlusion, Vascular; Humans; Ketanserin; Myo | 1987 |
Prosthetic replacement of the superior vena cava treated with antiplatelet agents.
Topics: Alkaloids; Animals; Benzylisoquinolines; Blood Vessel Prosthesis; Capsules; Delayed-Action Preparati | 1987 |
The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis Obliterans; Arteriovenous Shunt, Surgical; Aspirin; | 1987 |
Effect of the cyclo-oxygenase inhibitor indobufen on platelet accumulation in prosthetic vascular grafts.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Disease Models, Animal; Dogs; Drug Evaluati | 1986 |
Ticlopidine versus aspirin and dipyridamole: influence on platelet deposition and three-month patency of polytetrafluoroethylene grafts.
Topics: Animals; Anticoagulants; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Female; Femoral Arter | 1986 |
Platelet antagonists eliminate thromboembolic complications of small-diameter arterial prostheses.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Graft Occlusion, Vascular; Male; Platelet A | 1987 |
Adverse effects of high dose aspirin on platelet adhesion to experimental autogenous vein grafts.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Autoradiography; Carotid Arteries; Dipyridamole; Epo | 1985 |
Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts.
Topics: Animals; Aspirin; Blood Platelets; Cod Liver Oil; Dietary Fats; Dipyridamole; Dogs; Drug Combination | 1986 |
Aspirin or dipyridamole individually prevent lipid accumulation in primate vein bypass grafts.
Topics: Animals; Apolipoproteins B; Arteriovenous Shunt, Surgical; Aspirin; Cholesterol; Dipyridamole; Drug | 1985 |